Luis Coomer Email & Phone Number

Chapel Hill, NC, US

Durham, North Carolina, United States

• Participate in PCR assay development and validation for cell and gene therapy projects.
• Compile and process data, preparing summary tables and conducting peer reviews of raw data.
• Run assays independently and manage laboratory sample analysis.
• Maintain accurate inventory and order reagents, ensuring all laboratory supplies are available.
• Prepare buffers and use LIMS system for documentation, adhering to GxP guidelines.
• Conduct pipetting and adhere to strict safety requirements in a laboratory setting.

Chicago, Illinois, United States

• Efficiently conducted quality control testing on 800 daily samples using the Agilent Biotek Microplate Reader, achieving unparalleled accuracy and integrity in DNA/RNA concentration analysis, contributing significantly.
• Expertly managed the analysis of sizing data for 192 samples daily via Agilent TapeStation and LabChip GX systems, delivering detailed reports that informed management decisions and enhanced operational strategies.
• Optimized NGS library preparation for 768 samples across various sample types, enhancing sequencing efficiency and data quality through meticulous DNA/RNA processing and adapter ligation techniques.
• Conducts the setup and operation of Illumina NovaSeq 6000 sequencers, reducing downtime by 30% and conducting training that cut error rates by 20%, markedly improving lab productivity and data accuracy.

Nashville, Tennessee, United States

• Executed comprehensive Next-Generation Sequencing Panel (RPIP), targeting over 280 respiratory pathogens, including SARS-CoV-2, and identified more than 1200 AMR alleles, delivering critical data for the Gates.
• Enhanced genomic surveillance of SARS-CoV-2 by performing RNA sequencing on Illumina platforms (NovaSeq6000, NextSeq 550 Dx), processing up to 725 samples weekly, and identifying emerging variants through advanced.
• Pioneered the use of ThermoFisher’s QuantStudios software for precise analysis and interpretation of key SARS-CoV-2 regions, improving the accuracy of viral detection and monitoring.
• Achieved a 45% reduction in compound consumption for retesting by innovating direct 96 to 384 plating liquid handling methods, alongside conducting rigorous weekly quality control of all liquid handling instruments.